These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 27148944)
1. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy. Sulaiman RS; Merrigan S; Quigley J; Qi X; Lee B; Boulton ME; Kennedy B; Seo SY; Corson TW Sci Rep; 2016 May; 6():25509. PubMed ID: 27148944 [TBL] [Abstract][Full Text] [Related]
2. Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal Neovascularization. Wang H; Han X; Gambhir D; Becker S; Kunz E; Liu AJ; Hartnett ME PLoS One; 2016; 11(6):e0157748. PubMed ID: 27309355 [TBL] [Abstract][Full Text] [Related]
3. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models. Jhanji V; Liu H; Law K; Lee VY; Huang SF; Pang CP; Yam GH Br J Ophthalmol; 2011 Sep; 95(9):1309-15. PubMed ID: 21719569 [TBL] [Abstract][Full Text] [Related]
4. Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization. McAnally D; Siddiquee K; Gomaa A; Szabo A; Vasile S; Maloney PR; Divlianska DB; Peddibhotla S; Morfa CJ; Hershberger P; Falter R; Williamson R; Terry DB; Farjo R; Pinkerton AB; Qi X; Quigley J; Boulton ME; Grant MB; Smith LH PLoS One; 2018; 13(9):e0202436. PubMed ID: 30208056 [TBL] [Abstract][Full Text] [Related]
5. Secretogranin III as a novel target for the therapy of choroidal neovascularization. LeBlanc ME; Wang W; Ji Y; Tian H; Liu D; Zhang X; Li W Exp Eye Res; 2019 Apr; 181():120-126. PubMed ID: 30633921 [TBL] [Abstract][Full Text] [Related]
6. Chemical Proteomics Reveals Soluble Epoxide Hydrolase as a Therapeutic Target for Ocular Neovascularization. Sulaiman RS; Park B; Sheik Pran Babu SP; Si Y; Kharwadkar R; Mitter SK; Lee B; Sun W; Qi X; Boulton ME; Meroueh SO; Fei X; Seo SY; Corson TW ACS Chem Biol; 2018 Jan; 13(1):45-52. PubMed ID: 29193961 [TBL] [Abstract][Full Text] [Related]
7. Targeted Intraceptor Nanoparticle for Neovascular Macular Degeneration: Preclinical Dose Optimization and Toxicology Assessment. Zhang X; Bohner A; Bhuvanagiri S; Uehara H; Upadhyay AK; Emerson LL; Bondalapati S; Muddana SK; Fang D; Li M; Sandhu Z; Hussain A; Carroll LS; Tiem M; Archer B; Kompella U; Patil R; Ambati BK Mol Ther; 2017 Jul; 25(7):1606-1615. PubMed ID: 28236576 [TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization. Seo S; Suh W Mol Vis; 2017; 23():823-831. PubMed ID: 29225458 [TBL] [Abstract][Full Text] [Related]
9. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization. Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924 [TBL] [Abstract][Full Text] [Related]
10. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta. Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735 [TBL] [Abstract][Full Text] [Related]
11. Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis. Nakahara T; Morita A; Yagasaki R; Mori A; Sakamoto K Biol Pharm Bull; 2017; 40(12):2045-2049. PubMed ID: 29199229 [TBL] [Abstract][Full Text] [Related]